» Articles » PMID: 37199568

Microbiota in the Oral Cavity of School-age Children with HIV Who Started Antiretroviral Therapy at Young Ages in South Africa

Abstract

Background: Infancy is an important developmental period when the microbiome is shaped. We hypothesized that earlier antiretroviral therapy (ART) initiation would attenuate HIV effects on microbiota in the mouth.

Methods: Oral swabs were collected from 477 children with HIV (CWH) and 123 children without (controls) at two sites in Johannesburg, South Africa. CWH had started ART less than 3 years of age; 63% less than 6 months of age. Most were well controlled on ART at median age 11 years when the swab was collected. Controls were age-matched and recruited from the same communities. Sequencing of V4 amplicon of 16S rRNA was done. Differences in microbial diversity and relative abundances of taxa were compared between the groups.

Results: CWH had lower alpha diversity than controls. Genus-level abundances of Granulicatella, Streptococcus, and Gemella were greater and Neisseria and Haemophilus less abundant among CWH than controls. Associations were stronger among boys. Associations were not attenuated with earlier ART initiation. Shifts in genus-level taxa abundances in CWH relative to controls were most marked in children on lopinavir/ritonavir regimens, with fewer shifts seen if on efavirenz ART regimens.

Conclusion: A distinct profile of less diverse oral bacterial taxa was observed in school-aged CWH on ART compared with uninfected controls suggesting modulation of microbiota in the mouth by HIV and/or its treatments. Earlier ART initiation was not associated with microbiota profile. Proximal factors, including current ART regimen, were associated with contemporaneous profile of oral microbiota and may have masked associations with distal factors such as age at ART initiation.

Citing Articles

Human immunodeficiency virus and oral microbiota: mutual influence on the establishment of a viral gingival reservoir in individuals under antiretroviral therapy.

Ramos Pena D, Pillet S, Lourenco A, Pozzetto B, Bourlet T, Motta A Front Cell Infect Microbiol. 2024; 14:1364002.

PMID: 38660490 PMC: 11039817. DOI: 10.3389/fcimb.2024.1364002.

References
1.
Shiau S, Kuhn L, Strehlau R, Martens L, McIlleron H, Meredith S . Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment. BMC Pediatr. 2014; 14:39. PMC: 3927631. DOI: 10.1186/1471-2431-14-39. View

2.
McDonald D, Price M, Goodrich J, Nawrocki E, DeSantis T, Probst A . An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2011; 6(3):610-8. PMC: 3280142. DOI: 10.1038/ismej.2011.139. View

3.
Yang L, Dunlap D, Qin S, Fitch A, Li K, Koch C . Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function. Am J Respir Crit Care Med. 2019; 201(4):445-457. PMC: 7049920. DOI: 10.1164/rccm.201905-1016OC. View

4.
Akhigbe P, Chukwumah N, Folayan M, Divaris K, Obuekwe O, Omoigberale A . Age-specific associations with dental caries in HIV-infected, exposed but uninfected and HIV-unexposed uninfected children in Nigeria. BMC Oral Health. 2022; 22(1):429. PMC: 9512979. DOI: 10.1186/s12903-022-02421-w. View

5.
Navazesh M, Mulligan R, Pogoda J, Greenspan D, Alves M, Phelan J . The effect of HAART on salivary microbiota in the Women's Interagency HIV Study (WIHS). Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 100(6):701-8. DOI: 10.1016/j.tripleo.2004.10.011. View